Carmell Therapeutics's total assets for Q were $5.03M, a decrease of -18.55% from the previous quarter. CTCX total liabilities were $6.41M for the fiscal quarter, a -15.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.